Smartleaf Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83M Buy
3,922
+331
+9% +$167K 0.07% 261
2025
Q4
$1.7M Buy
3,591
+388
+12% +$180K 0.06% 263
2025
Q3
$1.35M Buy
3,203
+855
+36% +$331K 0.08% 260
2025
Q2
$891K Sell
2,348
-373
-14% -$134K 0.08% 279
2025
Q1
$931K Buy
2,721
+427
+19% +$137K 0.09% 247
2024
Q4
$685K Buy
2,294
+326
+17% +$114K 0.07% 275
2024
Q3
$794K Buy
1,968
+744
+61% +$272K 0.1% 233
2024
Q2
$420K Buy
1,224
+314
+35% +$102K 0.07% 267
2024
Q1
$302K Buy
910
+176
+24% +$53.8K 0.06% 281
2023
Q4
$194K Buy
+734
New +$181K 0.05% 318

Other funds holding HCA

Smartleaf Asset Management's HCA Position: Q1 2026 in Review

Smartleaf Asset Management increased its HCA Healthcare (HCA) stake by 9.2% in Q1 2026, buying an estimated $167K and bringing the position to 3,922 shares worth $1.83M. The position accounts for 0.07% of the portfolio, ranked #261.

Smartleaf Asset Management first reported a position in HCA in Q4 2023 and has held it in 10 quarters since. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Smartleaf Asset Management held 3,922 shares of HCA Healthcare worth $1.83M as of Q1 2026.
  • Smartleaf Asset Management bought 331 HCA Healthcare shares in Q1 2026, an estimated $167K.
  • HCA Healthcare made up 0.07% of Smartleaf Asset Management's portfolio in Q1 2026, its #261 holding.
  • Smartleaf Asset Management first reported a position in HCA Healthcare in Q4 2023 and has held it in 10 quarters since.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.